Page 9 - Pharma Dive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share it On Thursday, a committee of advisers to the Food and Drug Administration met for the second time in as many weeks to review an experimental coronavirus vaccine. The panel last week endorsed Pfizer and BioNTech's shot, clearing the way for the regulator to issue a historic emergency authorization the next day, and this week convened to review Moderna's candidate. Both vaccines were found in large trials of tens of thousands of volunteers to be strongly effective, preventing COVID-19 in nearly all participants who received them. FDA scientists affirmed the companies' claims in their ow...

Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline & Market: The M&A And Commercial Landscape By Mavra Nasir, Ph.D., Crystal Hsu, and Peter Bak, Ph.D., Back Bay Life Science Advisors In Part 1 and Part 2 of this three-part series, we covered the varied complexities of NASH driving an extremely challenging development landscape, along with the growing prevalence of NASH that has the life sciences industry in a race to develop a successful asset. In this last part of the series, we cover the M&A and commercial landscape implications, including historical and future deal trends,...

BioPharma